Watch Demo

Slovenia Antihypertensive Industry Outlook 2022 - 2026

See how Slovenia Antihypertensive performed compared to key markets such as Germany, Italy and Spain.

Key Market Indicators

Slovene antihypertensive medicine sales are set to reach nearly $4.4 million by 2026. In 2021, sales reached $4.5 million, down slightly from the year before. Since 2012, demand for these medicines has grown by an average of 5% each year. Slovenia ranked 20th in 2021, behind Latvia, which recorded sales of $4.5 million. Italy, Spain and Australia ranked second, third and fourth, respectively.

Slovenia Antihypertensive Market Data and Forecasts

How much will Slovenia Antihypertensive Market grow to 2026?

Forecast: Antihypertensive Medicine Sales in Slovenia
Forecast: Renin-Angiotensin System Medicine Sales in Slovenia
Forecast: Renin-Angiotensin System Medicine Sales in Slovenia
Forecast: Antihypertensive Medicine Sales in Slovenia
Forecast: Renin-Angiotensin System Medicine Sales in Slovenia
More in Antihypertensive Industry for 2027

Improve your Knowledge with the latest Indicators and Trends